Literature DB >> 28283266

Vasectomy reversal semen analysis: new reference ranges predict pregnancy.

Ahmad Majzoub1, Nicholas N Tadros1, A Scott Polackwich2, Rakesh Sharma1, Ashok Agarwal1, Edmund Sabanegh3.   

Abstract

OBJECTIVE: To study the semen analysis values required to cause a pregnancy after vasectomy reversal (VR). Vasectomy reversal is increasingly performed on men who wish to regain fertility after elective sterilization. Despite a thorough understanding of predictors of vasal patency after surgery, little is known about the patients' semen parameters and pregnancy potential.
DESIGN: Retrospective case-control study.
SETTING: Tertiary-care hospital. PATIENT(S): A total of 139 patients who underwent VR at the Cleveland Clinic from 2010 to 2014. INTERVENTION(S): Vasectomy reversal. MAIN OUTCOME MEASURE(S): Pregnancy, semen parameters. Data regarding patient and spouse ages, obstructive interval, intraoperative findings, procedure performed, postoperative semen results, and spontaneous pregnancy outcome were collected. Pearson and t tests were used to analyze categoric and numeric data, respectively. Average semen reference values were developed. RESULT(S): The mean obstructive interval was 9.5 ± 1.2 years. Spontaneous pregnancy was achieved by 49.6% of patients (69/139) and was directly related to better intraoperative vasal fluid quality and postoperative sperm concentration, motility, and strict morphology. The reference ranges of postoperative semen parameters of patients with spontaneous pregnancy were substantially lower than normal values published by the World Health Organization (WHO) in 2010. Spontaneous pregnancy was reported in 15%, 21.3%, and 14.8% of patients with a sperm concentration of <5 million/mL, a sperm motility of <10%, and a normal morphology of <1%, respectively. CONCLUSION(S): Normal ranges of semen parameters as established by the 2010 WHO standards may not adequately predict post-vasectomy reversal fertility. Significantly lower post-reversal semen parameters may be considered to be sufficient in previously fertile patients after reversal compared with the normal population.
Copyright © 2017 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Vasectomy; pregnancy rate; semen analysis; vasectomy reversal

Mesh:

Year:  2017        PMID: 28283266     DOI: 10.1016/j.fertnstert.2017.01.018

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  Vasectomy reversal utilizing fibrin glue.

Authors:  G Luke Machen; Ali M Mahmoud; Colin E Kleinguetl; Wencong Chen; Stephanie E Harris; Erin T Bird
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-03-20

2.  Reinforcing vasal suture technique improves sperm concentration and pregnancy rates in men undergoing vasovasostomy for vasectomy reversal.

Authors:  Joshua Savage; Madeleine Manka; Tiffany Rindels; Manaf Alom; Kiran L Sharma; Landon Trost
Journal:  Transl Androl Urol       Date:  2020-02

3.  Sperm origins and concentration do not impact the clinical outcomes in intracytoplasmic sperm injection cycles.

Authors:  Cen Yang; Ze-Hong Zhou; Dan-Ni Zheng; Xiao-Fei Xu; Jin Huang; Ying Lian; Jie Qiao
Journal:  Asian J Androl       Date:  2018 Sep-Oct       Impact factor: 3.285

4.  Comparison of intracytoplasmic sperm injection (ICSI) outcomes in infertile men with spermatogenic impairment of differing severity.

Authors:  Ping Ping; Zhong Zheng; Yi Ma; Sha-Sha Zou; Xiang-Feng Chen
Journal:  Asian J Androl       Date:  2022 May-Jun       Impact factor: 3.054

5.  Human sperm ion channel (dys)function: implications for fertilization.

Authors:  Sean G Brown; Stephen J Publicover; Christopher L R Barratt; Sarah J Martins da Silva
Journal:  Hum Reprod Update       Date:  2019-11-05       Impact factor: 15.610

Review 6.  Vasovasostomy and vasoepididymostomy: Review of the procedures, outcomes, and predictors of patency and pregnancy over the last decade.

Authors:  Takeshi Namekawa; Takashi Imamoto; Mayuko Kato; Akira Komiya; Tomohiko Ichikawa
Journal:  Reprod Med Biol       Date:  2018-05-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.